Refine by
Incontinence Articles & Analysis
36 news found
The potential side effects of these treatments are mostly around quality of life (erectile function, urinary incontinence, bowel discomfort). Focal treatment is where doctors target only the cancer that requires intervention and can be the bridge between active surveillance and radical treatment. ...
But those years are regularly accompanied by side effects such as incontinence, impotence and urinary and defecation complaints. I hope this treatment will lead to fewer side effects in certain groups of patients and therefore a better quality of ...
PC treatments include surgery and radiation therapy, bringing added risks of urinary incontinence and erectile dysfunction. The worry and fear men experience when considering the possible outcomes further fuel the angst of undergoing PC screening. ...
Prostate cancer is the most common type of cancer in men. Every year this diagnosis is made about 900 thousand times, in developed countries the disease affects up to 14% of the entire male population with oncology due to longer life expectancy. We spoke with adult prostate cancer survivors. ...
The Association, created by a group of specialists in the field of urology, focused on research of incontinence-related diseases and professional training in this field. Incorporating their experience and extensive knowledge is a great value to us. ...
Mera Medical Solutions will take advantage of the MEDICA showcaseto launch Harex® , a Premium device for the Control of Male Urinary Incontinence, worldwide. Harex® is assuming a substantial improvement in the quality of life of patients with Urinary Incontinence. ...
As a novel therapy, we must ensure that physicians who treat, and those who suffer from, urge incontinence have access to RENOVA and that we are ready to serve their needs. ...
There is a strong need for an alternative minimally-invasive solutions that offer rapid relief from BPH/LUTS and have no risk of urinary incontinence or impact on sexual function,” said Dr. Henry Woo, a world-renowned urological surgeon and Professor of Surgery at the University of Sydney, Australia. ...
Caldera Medical, a medical device company that develops best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, and Polyps announced the launch of Desara® TVez, an expansion to their Desara® Family of products. ...
The study will evaluate the safety and efficacy of Neuspera’s Nuvella™ system designed to treat overactive bladder (OAB) for patients with urinary urgency incontinence (UUI) symptoms. The system is the first sacral neuromodulation (SNM) device that offers a minimally invasive option, which may allow for a better patient experience and greater procedural versatility. ...
Recent and encouraging results, for treatment of Stress Urinary Incontinence (SUI) as well as Female Sexual Improvement (FSI), were presented at medical ...
The practice specializes in high-quality and attentive care across the fields of urinary incontinence, robotics, laparoscopy, and treatments for urologic cancers of the bladder, prostate, testicles, and kidneys. ...
He participated in the pivotal Medtronic trial, which led to InterStim’s original approval for the indication of urinary urge incontinence (UUI) in 1997. He was the national principal Investigator for the Medtronic InSite trial which demonstrated superior success of sacral neuromodulation when compared to standard medical therapy and the durability of sacral neuromodulation ...
RP effectively controls disease, but carries risk of significant side effects such as long-term erectile dysfunction and urinary incontinence. The TULSA procedure combines transurethral, robotically-driven therapeutic ultrasound with real-time visualization of temperature and automated control of heating from magnetic resonance thermometry. ...
As a novel therapy, we must ensure that physicians who treat, and those who suffer from, urge incontinence have access to RENOVA and that we are ready to serve their needs. ...
See www.orthodonticell.com BladderCell and B-Alive: BladderCell and B-Alive utilize bioelectric stimulation-controlled protein expressions to treat urinary incontinence. This is a significant improvement compared to current treatment options and will eliminate the adverse quality of life impediments associated with loss of bladder control. ...
Bluewind Medical, Ltd., developer of the innovative RENOVA iStim implantable neuromodulation device for treatment of urinary urgency incontinence, today announced it will be participating in the 33rd Annual Virtual Healthcare Conference organized by Piper Sandler on Nov 29th – Dec 2nd, 2021. ...
Bluewind Medical, Ltd., developer of the innovative RENOVA™ iStim implantable neuromodulation device for treatment of urinary urgency incontinence, today announced it will be participating in the 33rd Annual Virtual Healthcare Conference organized by Piper Sandler on Nov 29th – Dec 2nd, 2021. ...
Bluewind Medical, Ltd., developer of the innovative RENOVA iStim implantable neuromodulation device for treatment of urinary urgency incontinence, today announced the successful completion of patient enrollment in the OASIS pivotal clinical study that will be the basis by which the company will seek US-FDA (Food & Drug Administration) marketing clearance in the United States. ...
The first of three already conducted clinical pilots, relate to using MoreNova for female Sexual Improvement and Stress Urinary Incontinence. The pilots presented at the International Continence Society (ICS) 2021 Melbourne conference. Treatment was offered to women suffering from stress urinary incontinence, sexual dysfunction or both conditions. Initial ...